about
Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signalingImatinib enhances functional outcome after spinal cord injurySpinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release.Spatial and cellular characterization of mTORC1 activation after spinal cord injury reveals biphasic increase mainly attributed to microglia/macrophages.Nogo receptor 1 regulates formation of lasting memories.Visualizing RNA extrusion and DNA wrapping in transcription elongation complexes of bacterial and eukaryotic RNA polymerases.Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNFMammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation.Spinal release of tumour necrosis factor activates c-Jun N-terminal kinase and mediates inflammation-induced hypersensitivity.The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.Tsc2-Rheb signaling regulates EphA-mediated axon guidance.Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.Pentoxifylline and propentofylline prevent proliferation and activation of the mammalian target of rapamycin and mitogen activated protein kinase in cultured spinal astrocytes.Disrupted Neuroglial Metabolic Coupling after Peripheral Surgery.Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency.Response to the report, "A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury" by Sharp et al.Spatial organization of the somatosensory cortex revealed by osmFISH
P50
Q27313777-AC13FBFD-5DFF-4E91-A64A-043B251C0B67Q28480537-E1F85484-530B-4265-9B9E-A14ED3401A36Q35005722-12CC2082-364D-4799-8C47-20B6E2C9DC7DQ35140800-E00DBC9F-02B5-4EB0-9FF2-7D1589344CE4Q37420622-D9F87825-D2B1-4A6A-B696-44C49169F548Q38357484-4892D129-F072-4C59-9D21-68D07E0B6FABQ41875411-2EF6C37C-F7DB-485E-B5B4-85CBE8464D6BQ41904089-8B45546D-BC96-4377-BA8D-4748FA6C47F7Q41913159-A03575CB-E9D7-4E7E-BB9D-FDEE1107E26AQ41957358-606AAAAA-DD9F-4FA1-8A85-4D2E88A9ED18Q42075195-98E63284-07C6-4F91-90B6-9BF71B1095A6Q44348612-F3C8BA15-14E7-40EE-A65D-940D14387F7FQ46090948-ED88DFBC-09DA-4EB9-B35A-B9F65E5F2AAAQ47364334-6206CDEA-58A7-4EC4-AC6B-EF491F488B01Q54294566-A268694C-DF41-4787-BA9F-BE41D77562B8Q54352894-1859BAE0-FF1C-419E-B8F5-E213A70B36F6Q58083896-F19DBA17-3E45-4235-AE4B-DEC7F9CD3C14
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Simone Codeluppi
@ast
Simone Codeluppi
@en
Simone Codeluppi
@es
Simone Codeluppi
@nl
type
label
Simone Codeluppi
@ast
Simone Codeluppi
@en
Simone Codeluppi
@es
Simone Codeluppi
@nl
prefLabel
Simone Codeluppi
@ast
Simone Codeluppi
@en
Simone Codeluppi
@es
Simone Codeluppi
@nl
P106
P1153
8356442700
P31
P496
0000-0002-7053-0520